首页 | 本学科首页   官方微博 | 高级检索  
检索        

辛伐他汀与非诺贝特治疗2型糖尿病合并高血脂临床观察
引用本文:袁尚恒,何友作.辛伐他汀与非诺贝特治疗2型糖尿病合并高血脂临床观察[J].现代医药卫生,2008,24(16):2398-2399.
作者姓名:袁尚恒  何友作
作者单位:南部县人民医院 四川南部637300
摘    要:目的:探讨辛伐他汀与非诺贝特治疗2型糖尿病合并高血脂症临床的疗效.方法:将120例2型糖尿病合并高血脂症患者随机分为3组;辛伐他汀组、非诺贝特组、辛伐他汀与非诺贝特组;分别用药观察2型糖尿病合并高血脂症的疗效.结果:各组治疗后血清TC、LDL-C、TG均比治疗前下降,HDL-C比治疗前上升.联合用药组:TC、LDL-C、TG三项水平下降的幅度及升高HDL-C的幅度均高于单独用药的两组.结论:辛伐他汀与非诺贝特治疗2型糖尿病合并高血脂症临床的疗效满意.

关 键 词:高血脂  2型糖尿病  辛伐他汀  非诺贝特

Clinical observation of simvastatin anti fenofibrate in the treatment of type 2 diabetes with hyperlipemia
HE You-zuo,YUAN Shang-heng,HE You-zuo.Clinical observation of simvastatin anti fenofibrate in the treatment of type 2 diabetes with hyperlipemia[J].Modern Medicine Health,2008,24(16):2398-2399.
Authors:HE You-zuo  YUAN Shang-heng  HE You-zuo
Abstract:Objective:To investigate the curative effect of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia.Methods:120 patients with type 2 diabetes with hyperlipemia were randomly divided into three groups,namely simvastatin group,fenofibrate group and simvastatin and fenofibrate group;their results were observed respectively after administration.Results:After treatment,the serum levels of TC,LDL-C and TG in each group all decreased,while the serum level of HDL-C increased.The ranges of decreased level of serum TC,LDL-C and TG and increased level of serum HDL-C in simvastatin and fenofibrate group were all higher compared with those in two drugs used alone.Conclusion:The curative effect of simvastatin combined with fenofibrate in type 2 diabetes with hyperlipemia is satisfactory.
Keywords:Hyperlipemia  Type 2 diabetes  Simvastation  Fenofibrate
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号